Correlation Between Cyclacel Pharmaceuticals and Neurobiological Technologies
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and Neurobiological Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and Neurobiological Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuticals and Neurobiological Technologies, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and Neurobiological Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of Neurobiological Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and Neurobiological Technologies.
Diversification Opportunities for Cyclacel Pharmaceuticals and Neurobiological Technologies
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cyclacel and Neurobiological is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and Neurobiological Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobiological Technologies and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with Neurobiological Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobiological Technologies has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and Neurobiological Technologies go up and down completely randomly.
Pair Corralation between Cyclacel Pharmaceuticals and Neurobiological Technologies
If you would invest 0.01 in Neurobiological Technologies on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Neurobiological Technologies or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 5.88% |
| Values | Daily Returns |
Cyclacel Pharmaceuticals vs. Neurobiological Technologies
Performance |
| Timeline |
| Cyclacel Pharmaceuticals |
| Neurobiological Technologies |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cyclacel Pharmaceuticals and Neurobiological Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cyclacel Pharmaceuticals and Neurobiological Technologies
The main advantage of trading using opposite Cyclacel Pharmaceuticals and Neurobiological Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, Neurobiological Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobiological Technologies will offset losses from the drop in Neurobiological Technologies' long position.| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
| Neurobiological Technologies vs. Pharming Group NV | Neurobiological Technologies vs. Kane Biotech | Neurobiological Technologies vs. Health Sciences Gr | Neurobiological Technologies vs. MedMira |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |